However, Savas et al. demonstrated the importance of both the CD8+/CD103+ and CD8+/CD103− T cell subtypes in prolonging overall survival in triple-negative and HER2-positive breast cancer using single-cell profiling (p = 0.03) [26]. Here, CD8A is linked to breast carcinoma.